Association between a distinctive autoantibody-associated brainstem sensory syndrome and immune checkpoint inhibitors
This case series investigates the association of a segmental, facial, antibody-associated brainstem sensory syndrome with the immune checkpoint inhibitor pembrolizumab.
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
American Medical Association
2022
|